Table 4.
Comparison between main outcomes by group (Non-intervention vs. Intervention Group): graft type, and conditioning regimen
| Non-intervention Group | Intervention Group | ||||||
| Graft type | Conditioning regimen | Graft type | Conditioning regimen | ||||
| Related donor n = 57 | Myeloablative n = 42 | Nonablative n = 15 | Related donor n = 25 | Unrelated donor n = 9 | Myeloablative n = 28 | Nonablative n = 6 | |
| Hospital stay (days) - median (range) | 43 (15-101) | 43 (15-93) | 41 (28-101) | 41 (23-89) | 48 (24-117) | 42.5 (23-117) | 36 (24-78) |
| Infections - n (%) | 39 (68.4) | 25 (59.5) | 14 (93.3) | 17 (68) | 5 (55.5) | 18 (64.3) | 4 (6.66) |
| In-hospital deaths - n (%) | 9 (15.8) | 9 (15.8) | 0 | 5 (20) | 5 (55.5) | 7 (25) | 1 (16.6) |
| Death at 6 months - n (%) | 14 (24.6) | 12 (28.6) | 2 (13.3) | 8 (32) | 3 (33.3) | 10 (35.7) | 1 (16.6) |
| Death at 12 months - n (%) | 29 (50.9) | 22 (52.4) | 7 (4.6) | 7 (28) | 3 (33.3) | 10 (35.7) | 0 |
| Number post-HSCT admissions - median (range) | 2 (0-16) | 2 (0-16) | 2(0-15) | 3 (1-14) | 7 (0-14) | 5 (1-14) | 2.5 (0-12) |
| Chronic GVHD - n (%) | |||||||
| None | 34 (59.65) | 29 (69) | 5 (33.3) | 20 (80) | 9 (100) | 24 (85.7) | 5 (83.3) |
| Limited | 13 (22.8) | 8 (19) | 5 (33.3) | 4 (16) | 0 | 4 (14.3) | 0 |
| Extensive | 10 (17.5) | 5 (11.9) | 5 (33.3) | 1 (4) | 0 | 0 | 1 (16.6) |
| Acute GVHD - n (%) | |||||||
| Grade I/II | 14 (24.6) | 8 (19) | 6 (40) | 9 (36) | 3 (33.3) | 10 (35.7) | 2 (33.3) |
| Grade III/IV | 10 (17.5) | 7 (16.6) | 3 (20) | 3 (12) | 1 (11.1) | 3 (10.7) | 1 (16.6) |
| CMV - n (%) | 10 (17.5) | 8 (19) | 2 (13.3) | 7 (28) | 4 (44.4) | 8 (28.6) | 3 (50) |
| In-hospital weight loss > 10% - n (%) | 22 (38.6) | 14 (33.3) | 8 (53.3) | 10 (40) | 5 (55.5) | 12 42.8) | 3 (50) |
| Neutropenia - n (%) | 55 (96.5) | 41 (97.6) | 14 (93.3) | 20 (80) | 8 (88.8) | 22 (78.5) | 6 (100) |
HSCT: Hematopoietic stem cell transplantation; GVHD: Graft versus host disease; CMV: Cytomegalovirus